Author: oncologs.com

In a groundbreaking study from Weill Cornell Medicine, scientists have unveiled new molecular insights into how cells meticulously preserve the integrity of chromosome ends during cell division. This intricate process, fundamental to cellular health, involves protein complexes that regulate the activity of telomerase—the enzyme that

In a groundbreaking initiative poised to reshape cancer screening protocols in developing regions, researchers have launched the CHinA National CancEr Screening (CHANCES) trial, a large-scale randomized controlled study focused on optimizing screening strategies for lung and colorectal cancers. This ambitious five-year project, unprecedented in scale

City of Hope, a leading institution in cancer research and treatment, is set to showcase a wide array of groundbreaking studies and clinical advances at the upcoming AACR Annual Meeting 2025 in Chicago. This prestigious conference, held from April 25 to April 30, will feature

In a comprehensive global analysis spanning over three decades, researchers have uncovered pivotal trends and disparities in the burden of soft tissue and extraosseous sarcomas. These malignant tumors, arising from connective tissues rather than bone, represent a rare but clinically significant subset of cancers. The

In a groundbreaking advancement in cancer therapeutics, researchers have unveiled a novel approach to combat resistance to osimertinib, a frontline treatment for advanced non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations. The study, led by Professor Kenneth To from The

In a groundbreaking study published in the latest issue of BMC Cancer, researchers have elucidated the pivotal role of circulating tumor cells (CTCs) in the prognosis and treatment response of patients suffering from advanced gallbladder adenocarcinoma (aGA). This research marks one of the first comprehensive

Pancreatic cancer (PC) remains one of the deadliest malignancies globally, maintaining its rank as the seventh leading cause of cancer-related mortality. Despite advances in some areas of oncology, progress in reducing the global impact of pancreatic cancer has been slow and unevenly distributed. Recent research

A groundbreaking advancement in cancer therapeutics promises to revolutionize the way large molecule drugs are delivered into cells, overcoming a longstanding obstacle in drug design. Researchers from Duke University School of Medicine, the University of Texas Health Science Center at San Antonio, and the University

In a groundbreaking multi-center retrospective study published in BMC Cancer, researchers have unveiled compelling evidence supporting the use of a composite recurrence risk score (CR-score) model to guide ovarian function suppression (OFS) therapy in premenopausal women diagnosed with hormone receptor-positive (HR+), human epidermal growth factor

In a groundbreaking study from the University of California, Riverside, researchers have unveiled pivotal mechanisms by which adult stem cells preserve their regenerative identity. Published in the upcoming May 2025 issue of Genes & Development, this research highlights the indispensable role of histone chaperones—specialized proteins